Sur le marche des peptides de recherche, le BPC-157 reste l'un des plus demandes et des plus documentes en litterature preclinique, juste derriere le TB-500 et le CJC-1295/Ipamorelin
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Personal Opinion: Having reviewed extensive research on peptides for hair applications, I find GHK-Cu particularly compelling because it addresses hair loss through so many different pathways simultaneously
People were going to seek out these peptides regardless, so building a legal, regulated pathway with actual quality standards is just pure common sense
However, extremely high levels may indicate an underlying condition such as liver disease, kidney disease, or certain types of cancer
This extended duration reflects improved resistance to peptidase degradation